This activity is expired and is no longer available for CME credit.


Rapid Response From Retina World Congress – Transitioning Treatment in Diabetic Retinopathy

Author(s)/Faculty: Rishi P. Singh, MD; W. Lloyd Clark, MD; Carl D. Regillo, MD, FACS
Release Date: 3/31/2019Expiration Date: 3/30/2020
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, offering delayed or arrested disease progression and the possibility of regaining lost vision for many patients. Notable among the diseases that have been found to respond well to intravitreal therapy are age-related macular degeneration, retinal vein occlusion, diabetic macular edema, and, more recently, diabetic retinopathy (DR). The discovery that intravitreal therapy can be effective in treating DR has spurred further research exploring the outcomes of treatment regimens. In this continuing medical education activity, a panel of expert physicians will examine effective ways to treat DR and will discuss clinical studies and data presented at the Retina World Congress meeting in Fort Lauderdale, Florida.